5-Hydroxyindoleacetic Acid (5-HIAA) plays a crucial role in the biological breakdown of serotonin, a key neurotransmitter synthesized from the amino acid tryptophan.
Predominantly produced in the gastrointestinal tract's enterochromaffin cells, serotonin also impacts various body functions such as mood regulation, appetite, and sleep when present in the central nervous system and platelets.
The transformation of serotonin into 5-HIAA is facilitated by the enzyme monoamine oxidase (MAO), predominantly within the liver, making 5-HIAA a major serotonin metabolite. This metabolite is then expelled from the body through urine, serving as a valuable marker for conditions like carcinoid tumors, which lead to elevated serotonin and subsequently 5-HIAA levels.
In essence, while 5-HIAA does not participate directly in neurotransmission, its concentration in bodily fluids reflects the metabolic activity of serotonin.
Therefore, measuring 5-HIAA, particularly in urine, is instrumental in diagnosing and monitoring diseases linked to altered serotonin metabolism. This includes not just carcinoid tumors but also disorders affecting gastrointestinal function, blood clotting mechanisms, and various psychiatric conditions.
5-Hydroxyindoleacetic Acid (5-HIAA) is primarily known as a marker of serotonin metabolism.
Serotonin is also commonly known as 5-HT due to its chemical structure, 5-hydroxytryptamine. Serotonin itself is synthesized from the amino acid tryptophan through hydroxylation and decarboxylation processes.
Primarily found in the gastrointestinal tract's enterochromaffin cells, serotonin also exists in the central nervous system and platelets, influencing various biological functions such as mood, appetite, and sleep.
5-HIAA is produced when serotonin is broken down by the enzyme monoamine oxidase (MAO), with the liver playing a crucial role in its metabolism. The end product, 5-HIAA, is then excreted in the urine.
Testing for elevated levels of 5-HIAA, typically through urine analysis, is essential for diagnosing conditions like carcinoid tumors, where excessive serotonin is converted into 5-HIAA. This testing reflects not only the presence of these tumors but also the body's overall serotonin activity.
Serotonin’s diverse roles include impacting vascular functions such as blood clotting, where it induces vasoconstriction or vasodilation based on its concentration.
Moreover, it affects gastrointestinal functions by regulating bowel movements and gut motility, often influenced by dietary components and pharmacological agents.
5-HIAA is the main catabolic product of serotonin. Chemically, 5-HIAA belongs to the class of compounds known as indoleacetic acids.
5-Hydroxyindoleacetic acid (5-HIAA) is primarily produced in the body as a metabolite of serotonin, a neurotransmitter synthesized in the raphe nuclei located within the brainstem, and in the gastrointestinal tract.
The conversion of serotonin to 5-HIAA occurs mainly through the action of the enzyme monoamine oxidase (MAO), found in the mitochondrial membranes of neurons.
This process allows for the measurement of serotonin levels indirectly through the analysis of 5-HIAA in the cerebrospinal fluid (CSF), providing insights into the serotonergic activity in the central nervous system.
Additionally, a significant portion of serotonin not confined to neuronal synthesis is produced by enterochromaffin cells in the gastrointestinal tract, contributing to the levels of 5-HIAA found in the urine.
Monoamine oxidase (MAO) present in various peripheral tissues including the liver and gastrointestinal tract plays a critical role in breaking down serotonin to 5-hydroxyindoleacetic acid (5-HIAA).
This widespread presence of MAO helps regulate serotonin levels throughout the body and facilitates the excretion of its metabolite, 5-HIAA, through the urine.
This makes testing urine levels of 5-HIAA useful for diagnosing certain tumors and other medical conditions.
While 5-HIAA itself is not active in neurotransmission, its levels in the body reflect the state of serotonin metabolism.
Altered levels of 5-HIAA in the body can indicate several health issues, most notably neuroendocrine tumors such as carcinoid tumors. These tumors often secrete excessive amounts of serotonin, leading to elevated levels of 5-HIAA, particularly in the urine. [4.]
This elevation is a key diagnostic marker used to identify such tumors.
Beyond neuroendocrine tumors, altered 5-HIAA levels may also be observed in various other conditions, including inflammatory bowel disease, fibromyalgia, and certain psychiatric disorders, where serotonin metabolism is disrupted. [1., 6., 8.]
Neuroendocrine tumors are a broad category of tumors that develop from cells of the neuroendocrine system, which are cells that have characteristics of both nerve cells and hormone-producing endocrine cells.
Carcinoid tumors are a specific subtype of neuroendocrine tumors that originate from enterochromaffin cells and most commonly affect the gastrointestinal tract and lungs.
Carcinoid tumors and certain other neuroendocrine tumors can lead to elevated levels of 5-hydroxyindoleacetic acid (5-HIAA) in the body.
Carcinoid tumors have the ability to produce excessive amounts of the neurotransmitter serotonin.
When serotonin is metabolized, one of the end products is 5-HIAA, which is then excreted in urine. A significantly increased level of 5-HIAA, when accompanied by symptoms of carcinoid syndrome, is suggestive but not diagnostic of a carcinoid tumor.
However, it is important to note that the urine 5-HIAA test alone may miss up to 50% of carcinoid tumor cases, necessitating the use of additional tests like blood serotonin and chromogranin A levels. [5.]
Midgut carcinoid tumors, originating from the jejunum, ileum, and proximal colon, are more likely to produce excess serotonin and consequently elevate 5-HIAA levels compared to foregut carcinoids from the lung or stomach.
Beyond carcinoid tumors, other neuroendocrine tumors that overproduce serotonin can also lead to elevated 5-HIAA levels. Elevated 5-HIAA levels have also been reported in pheochromocytomas and pancreatic neuroendocrine tumors that produce serotonin.
Therefore, measuring urinary 5-HIAA levels serves as an important biomarker for the diagnosis and monitoring of carcinoid tumors and other neuroendocrine tumors characterized by excessive serotonin production.
Testing for 5-Hydroxyindoleacetic Acid (5-HIAA) is commonly done via urine, although it may be done in blood. In certain specialized medical or research settings, testing 5-HIAA levels in CSF may be performed.
Patients are typically required to collect their urine over a 24-hour period in a provided container.
Many medications and foods can interfere with test results, so it is essential to follow all test preparation instructions carefully.
The following medications can decrease test results for 5-HIAA: [1.]
The following medications and situations can increase test results for 5-HIAA: [1.]
The following foods can alter test results for 5-HIAA: [1.]
The reference range for 5-HIAA urine tests may vary somewhat depending on the laboratory company used, so it is important to consult with the laboratory company that is analyzing the sample.
One reference reports a normal range of 5-HIAA in urine as: [10.]
24-hour urine for 5-HIAA: 2-8 mg/24 hr or 10-40 μmol/day
Optimal levels of 5-HIAA in urine fall within the reference range, often 2-8 mg/24 hour, or 10-40 μmol/day. Higher or lower levels may indicate conditions such as tumors or decreased serotonin production.
It is essential to interpret results within the individual’s clinical context, taking into account digestive and mental health symptoms.
High levels of 5-HIAA can indicate an overactive serotonin system, often seen in certain types of neuroendocrine tumors such as carcinoid tumors that produce serotonin excessively.
Low levels of 5-HIAA might suggest deficiencies in serotonin production or issues with its metabolism.
Click here to compare testing options and order 5-HIAA testing.
[1.] 5-Hydroxyindoleacetic Acid (5-HIAA): Reference Range, Interpretation, Collection and Panels. eMedicine. Published online June 22, 2022. https://emedicine.medscape.com/article/2089202-overview?form=fpf
[2.] Bakshi A, Tadi P. Biochemistry, Serotonin. [Updated 2022 Oct 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560856/
[3.] Ewang-Emukowhate M, Nair D, Caplin M. The role of 5-hydroxyindoleacetic acid in neuroendocrine tumors: the journey so far. International Journal of Endocrine Oncology. 2019;6(2):IJE17. doi:https://doi.org/10.2217/ije-2019-0001
[4.] Feldman JM. Urinary serotonin in the diagnosis of carcinoid tumors. Clin Chem. 1986 May;32(5):840-4. PMID: 2421946.
[5.] Frequently Asked Questions. Carcinoid Cancer Foundation. Accessed May 13, 2024. https://www.carcinoid.org/for-patients/more-information/faq/
[6.] Jayamohananan H, Manoj Kumar MK, T P A. 5-HIAA as a Potential Biological Marker for Neurological and Psychiatric Disorders. Adv Pharm Bull. 2019 Aug;9(3):374-381. doi: 10.15171/apb.2019.044. Epub 2019 Aug 1. PMID: 31592064; PMCID: PMC6773935.
[7.] Joy T, Walsh G, Tokmakejian S, Van Uum SH. Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake. Can J Gastroenterol. 2008 Jan;22(1):49-53. doi: 10.1155/2008/472159. PMID: 18209781; PMCID: PMC2659120.
[8.] Juhl JH. Fibromyalgia and the serotonin pathway. Altern Med Rev. 1998 Oct;3(5):367-75. PMID: 9802912.
[9.] Lenchner JR, Santos C. Biochemistry, 5 Hydroxyindoleacetic Acid. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551684/
[10.] Pagana KD, Pagana TJ, Pagana TN. Mosby's Diagnostic & Laboratory Test Reference. 14th ed. St. Louis, MO: Elsevier; 2019. 528.